Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zosano Pharma Corporation ZSANQ

Healthcare Biotechnology
Zosano Pharma Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Zosano Pharma Corp is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K... see more

Recent & Breaking News (EXPM:ZSANQ)

Zosano Pharma Receives Preliminary FDA Communication on Qtrypta(TM) NDA

GlobeNewswire September 30, 2020

Zosano Pharma to Present at the Cantor Virtual Global Healthcare Conference

GlobeNewswire September 9, 2020

Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference

GlobeNewswire September 3, 2020

Zosano Announces Pricing of Public Offering of Common Stock

GlobeNewswire September 1, 2020

Zosano Pharma Announces Proposed Public Offering of Common Stock

GlobeNewswire August 31, 2020

Zosano Pharma Announces Agreement to Collaborate with Mitsubishi Tanabe Pharma Corporation

GlobeNewswire August 18, 2020

Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta(TM)

GlobeNewswire August 6, 2020

Zosano Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire August 6, 2020

Zosano Pharma to Present at the BTIG Biotechnology Conference 2020

GlobeNewswire August 3, 2020

Zosano Pharma to showcase new post-hoc analyses of Qtrypta's (M207) clinical trial data comparing key efficacy results from the pivotal study and the open-label long term safety study on the 2020 American Headache Society's Virtual Annual Scientific Meeting Platform

GlobeNewswire June 13, 2020

Zosano Pharma Announces Change to a Virtual Meeting Format for 2020 Annual Meeting of Stockholders

GlobeNewswire June 11, 2020

Zosano Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewswire May 14, 2020

Zosano Pharma Announces the Appointment of Christine Matthews as Chief Financial Officer

GlobeNewswire May 1, 2020

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2019 Financial Results

GlobeNewswire March 13, 2020

Zosano Pharma Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire March 6, 2020

Zosano Pharma Announces $11 Million Registered Direct Offering Priced At-the-Market

GlobeNewswire March 5, 2020

Zosano Pharma Announces FDA Acceptance of 505(b)(2) New Drug Application for Qtrypta(TM) for the Acute Treatment of Migraine

GlobeNewswire March 4, 2020

Zosano Pharma Announces Pricing of $8.0 Million Public Offering of Common Stock and Warrants

GlobeNewswire February 12, 2020

Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

GlobeNewswire February 11, 2020

Zosano Announces FDA Submission of New Drug Application for Qtrypta

GlobeNewswire December 23, 2019